Zusammenfassung
Die Fortschritte bei den bildgebenden Verfahren der weiblichen Brust haben in den letzten Jahren die Diagnostik, die Therapie und die Prognose des Mammakarzinoms erheblich beeinflusst. Die Früherkennungsmammographie in traditioneller oder digitaler Technik gilt heute als der „Goldstandard“ für die frühzeitige Detektion von Brustkrebs. Weitere Modalitäten wie die Mammasonographie und die kontrastmittelgestützte MR-Mammographie spielen bei der bildgebenden Diagnostik, im Staging sowie in der Nachsorge des Mammakarzinoms eine wichtige Rolle. Die perkutane Nadelbiopsie stellt eine schnellere, weniger invasive und kostengünstigere Methode dar als die diagnostische Exzision für die histologische Sicherung der Diagnose. Neue Modalitäten wie Tomosynthese der Brust, kontrastverstärkte Mammographie und Positronenemissionstomographie erheben den Anspruch, zu einer weiteren Verbesserung der Bildgebung beizutragen. Weitere Studien sind notwendig, um diese neuen Methoden an die klinischen Bedürfnisse zu adaptieren und ihren Stellenwert im klinischen Alltag zu bewerten.
Abstract
Advances in female breast imaging have substantially influenced the diagnosis, therapy, and prognosis of breast cancer in the past few years. Mammography using conventional or digital technique is considered the gold standard for the early detection of breast cancer. Other modalities such as breast ultrasound and contrast-enhanced magnetic resonance imaging of the breast play an important role in diagnostic imaging, staging, and follow-up of breast cancer. Percutaneous needle biopsy is a faster, less invasive, and more cost-effective method than surgical biopsy for verifying the histological diagnosis. New methods such as breast tomosynthesis, contrast-enhanced mammography, and positron emission tomography promise to further improve breast imaging. Further studies are mandatory to adapt these new methods to clinical needs and to evaluate their performance in clinical practice.
Literatur
Armstrong K, Moye E, Williams S et al. (2007) Screening mammography in women 40 to 49 years of age: a systematic review for the American College of Physicians. Ann Intern Med 146: 516–526
Avril N, Rose CA, Schelling M et al. (2000) Breast imaging with positron emission tomography and fluorine-18 fluorodeoxyglucose: use and limitations. J Clin Oncol 18: 3495–3502
Barlow WE, Lehman CD, Zheng Y et al. (2002) Performance of diagnostic mammography for women with signs or symptoms of breast cancer. J Natl Cancer Inst 94: 1151–1159
Bassett LW, Kimme-Smith C (1991) Breast sonography. AJR Am J Roentgenol 156: 449–455
Bassett LW, Ysrael M, Gold RH et al. (1991) Usefulness of mammography and sonography in women less than 35 years of age. Radiology 180: 831–835
Bedrosian I, Mick R, Orel SG et al. (2003) Changes in the surgical management of patients with breast carcinoma based on preoperative magnetic resonance imaging. Cancer 98: 468–473
Delorme S (2004) Mammakarzinom. Sonographie und Magnetresonanzmammographie. Radiologe 44: 621–637
Eltahir A, Jibril JA, Squair J et al. (1999) The accuracy of „one-stop“ diagnosis for 1,110 patients presenting to a symptomatic breast clinic. J R Coll Surg Edinb 44: 226–230
Fischer U, Helbich T (2006) ACR BI-RADS: Illustrierte Anleitung zur einheitlichen Befunderstellung von Mammographie, Mammasonographie und MR Mammographie. Thieme, Stuttgart New York
Fischer U, Kopka L, Grabbe E (1999) Breast carcinoma: effect of preoperative contrast-enhanced MR imaging on the therapeutic approach. Radiology 213: 881–888
Gennaro G, di Maggio C (2006) Dose comparison between screen/film and full-field digital mammography. Eur Radiol 16: 2559–2566
Gur D (2007) Tomosynthesis: potential clinical role in breast imaging. AJR Am J Roentgenol 189: 614–615
Helbich TH, Stadler A, Wolf G (1999) Staging des Mammakarzinoms. Wertigkeit bildgebender Verfahren. Radiologe 39: 546–554
Jong RA, Yaffe MJ, Skarpathiotakis M et al. (2003) Contrast-enhanced digital mammography: initial clinical experience. Radiology 228: 842–850
Kreienberg R, Kopp I, Lorenz W et al. (2004) Diagnostik, Therapie und Nachsorge des Mammakarzinoms der Frau – Eine nationale S3-Leitlinie. Deutsche Krebsgesellschaft e.V., Informationszentrum für Standards in der Onkologie (ISTO), Frankfurt
Kriege M, Brekelmans CT, Obdeijn IM et al. (2006) Factors affecting sensitivity and specificity of screening mammography and MRI in women with an inherited risk for breast cancer. Breast Cancer Res Treat 100: 109–119
Kuhl C (2007) The current status of breast MR imaging. Part I. Choice of technique, image interpretation, diagnostic accuracy, and transfer to clinical practice. Radiology 244: 356–378
Kuhl CK (2007) Current status of breast MR imaging. Part 2. Clinical applications. Radiology 244: 672–691
Kuhl CK, Schrading S, Weigel S et al. (2005) Die „EVA“-Studie: Evaluierung der Leistungsfähigkeit diagnostischer Verfahren (Mammographie, Sonographie, MRT) zur sekundären und tertiären Prävention des familiären Mammakarzinoms – Zwischenergebnisse nach der ersten Hälfte der Förderungsperiode. Fortschr Roentgenstr 177: 818–827
Kuhl CK, Schrading S, Bieling HB et al. (2007) MRI for diagnosis of pure ductal carcinoma in situ: a prospective observational study. Lancet 370: 485–492
Lehman CD, Gatsonis C, Kuhl CK et al. (2007) MRI evaluation of the contralateral breast in women with recently diagnosed breast cancer. N Engl J Med 356: 1295–1303
Lewin JM, Isaacs PK, Vance V et al. (2003) Dual-energy contrast-enhanced digital subtraction mammography: feasibility. Radiology 229: 261–268
Liberman L (2000) Centennial dissertation. Percutaneous imaging-guided core breast biopsy: state of the art at the millennium. AJR Am J Roentgenol 174: 1191–1199
Liberman L (2002) Percutaneous image-guided core breast biopsy. Radiol Clin North Am 40: 483–500
Liberman L, Morris EA, Dershaw DD et al. (2003) MR imaging of the ipsilateral breast in women with percutaneously proven breast cancer. AJR Am J Roentgenol 180: 901–910
Liberman L, Morris EA, Kim CM et al. (2003) MR imaging findings in the contralateral breast of women with recently diagnosed breast cancer. AJR Am J Roentgenol 180: 333–341
Madjar H, Rickard M, Jellins J et al. (1999) IBUS guidelines for the ultrasonic examination of the breast. IBUS International Faculty. International Breast Ultrasound School. Eur J Ultrasound 9: 99–102
Morris EA, Liberman L, Ballon DJ et al. (2003) MRI of occult breast carcinoma in a high-risk population. AJR Am J Roentgenol 181: 619–626
Page DL, Dupont WD, Rogers LW et al. (1982) Intraductal carcinoma of the breast: follow-up after biopsy only. Cancer 49: 751–758
Park JM, Franken EA Jr, Garg M et al. (2007) Breast tomosynthesis: present considerations and future applications. Radiographics [Suppl 1] 27: S231–240
Parker SH, Klaus AJ, McWey PJ et al. (2001) Sonographically guided directional vacuum-assisted breast biopsy using a handheld device. AJR Am J Roentgenol 177: 405–408
Pediconi F, Catalano C, Roselli A et al. (2007) Contrast-enhanced MR mammography for evaluation of the contralateral breast in patients with diagnosed unilateral breast cancer or high-risk lesions. Radiology 243: 670–680
Perlet C, Heywang-Kobrunner SH, Heinig A et al. (2006) Magnetic resonance-guided, vacuum-assisted breast biopsy: results from a European multicenter study of 538 lesions. Cancer 106: 982–990
Pfarl G, Helbich TH, Riedl CC et al. (2002) Stereotaktische Nadelbiopsie der Brust: Diagnosesicherheit verschiedener Biopsie-Systeme und Nadelkaliber. Fortschr Roentgenstr 174: 614–619
Pfarl G, Helbich TH, Riedl CC et al. (2002) Stereotactic 11-gauge vacuum-assisted breast biopsy: a validation study. AJR Am J Roentgenol 179: 1503–1507
Pisano ED, Gatsonis C, Hendrick E et al. (2005) Diagnostic performance of digital versus film mammography for breast-cancer screening. N Engl J Med 353: 1773–1783
Pisano ED, Hendrick RE, Yaffe MJ et al. (2008) Diagnostic accuracy of digital versus film mammography: exploratory analysis of selected population subgroups in DMIST. Radiology 246: 376–383
Rosen PP, Kosloff C, Lieberman PH et al. (1978) Lobular carcinoma in situ of the breast. Detailed analysis of 99 patients with average follow-up of 24 years. Am J Surg Pathol 2: 225–251
Rosen EL, Turkington TG, Soo MS et al. (2005) Detection of primary breast carcinoma with a dedicated, large-field-of-view FDG PET mammography device: initial experience. Radiology 234: 527–534
Schorn C, Fischer U, Luftner-Nagel S et al. (1999) MRI of the breast in patients with metastatic disease of unknown primary. Eur Radiol 9: 470–473
Schulz-Wendtland R. (2007) Mammasonographie: Wellness – IGEL. Fortschr Röntgenstr 179: S1
Schulz-Wendtland R, Becker N, Bock K et al. (2007) Mammographiescreening. Radiologe 47: 359–369
Seely JM, Nguyen ET, Jaffey J (2007) Breast MRI in the evaluation of locally recurrent or new breast cancer in the postoperative patient: correlation of morphology and enhancement features with the BI-RADS category. Acta Radiol 28: 1–8
Smith RA, Saslow D, Sawyer KA et al. (2003) American Cancer Society guidelines for breast cancer screening: update 2003. CA Cancer J Clin 53: 141–169
Statistisches Bundesamt (2006) Datenreport 2006. Bundeszentrale für politische Bildung, Bonn, http://www.destatis.de/jetspeed/portal/cms/Sites/destatis/Internet/DE/Content/Publikationen/Querschnittsveroeffentlichungen/Datenreport/Downloads/1Gesundheit,property=file.pdf
Watermann D, Madjar H, Sauerbrei W et al. (2004) Assessment of breast cancer vascularisation by Doppler ultrasound as a prognostic factor of survival. Oncol Rep 11: 905–910
Wittekind C, Klimpfinger M, Sobin LH (2005) TNM Atlas. Illustrierter Leitfaden zur TNM/pTNM-Klassifikation maligner Tumoren. Springer, Berlin Heidelberg New York
Interessenkonflikt
Der korrespondierende Autor gibt an, dass kein Interessenkonflikt besteht.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Funke, M., Villena, C. Bildgebende Diagnostik des Mammakarzinoms. Radiologe 48, 601–614 (2008). https://doi.org/10.1007/s00117-008-1676-z
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00117-008-1676-z